SCHEMBL5993383

SCHEMBL5993383

CC(C)COC(=O)N1CCC(NCc2ccc(F)cc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.51
TSHR P16473 1/20 0.51
LMNA P02545 2/20 0.48
HTT P42858 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
HTR2A P28223 6/20 0.48
BCHE P06276 1/20 0.48
ACHE P22303 1/20 0.48
BACE1 P56817 1/20 0.48
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 1/20 0.47
GAA P10253 1/20 0.47
ABCB11 O95342 1/20 0.46
CYP1A2 P05177 1/20 0.46
ADRB2 P07550 1/20 0.46
CHRM2 P08172 1/20 0.46
CHRM1 P11229 1/20 0.46
DRD1 P21728 1/20 0.46
TBXA2R P21731 1/20 0.46
SLC6A2 P23975 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3913456 0.84 ALDH1A1 (0.59) MAPTLMNAHTTKDM4EALDH1A1
SCHEMBL13191196 0.84 MAPT (0.52) MAPTTSHRLMNAHTTSMN1; SMN2
SCHEMBL342045 0.82 ACHE (0.59) TSHRHTTSMN1; SMN2BCHEACHE
SCHEMBL4139902 0.82 DNMT3A (0.56) MAPTTSHRHTTHTR2ABCHE
SCHEMBL13911887 0.81 BCHE (0.56) MAPTTSHRSMN1; SMN2BCHEACHE
Hydrochloric Acid SCHEMBL6538885 0.80 BCHE (0.54) MAPTTSHRSMN1; SMN2BCHEACHE
SCHEMBL3712791 0.79 ACHE (0.60) TSHRSMN1; SMN2BCHEACHEBACE1
SCHEMBL9699514 0.76 KMT2A (0.70) KDM4EALDH1A1CHRM2CHRM1L3MBTL1
SCHEMBL3652318 0.76 TEAD1 (0.56) TSHRBCHEACHEBACE1ALDH1A1
SCHEMBL5308786 0.76 THRB (0.62) SMN1; SMN2GAAL3MBTL1GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060079554-A1 Inhibitors of monomine uptake ELI LILLY AND COMPANY 2006-04-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060079554-A1 Inhibitors of monomine uptake SLC6A2, SLC18A2, SLC6A3 MAPT 993/4885TSHR 1216/4885LMNA 3580/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.